Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Harper, Patrick C; Smith, Mark M; Brinkman, Nathan J; Passe, Melissa A; Schroeder, Darrell R; Said, Sameh M; Nuttall, Gregory A; Oliver, William C; Barbara, David W.
J Cardiothorac Vasc Anesth
; 32(1): 151-157, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29217234
Perioperative Use of Coagulation Factor Concentrates in Patients Undergoing Cardiac Surgery.
A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Etomidate for anesthesia induction: friends or foe in major cardiac surgery?
The impact of an algorithm on the optimization of beta-blockers after cardiac surgery.
Sedation After Cardiac Surgery: Is One Drug Better Than Another?
Perioperative statin therapy in cardiac surgery: a meta-analysis of randomized controlled trials.
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa.
Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis.
Patients Discharged From the Intensive Care Unit on a Dopamine Infusion-A Retrospective, Observational Study.
Colloids in Cardiac Surgery-Friend or Foe?